Mackenbach JP, Bouvier-Colle MH, Jougla E. “Avoidable” mortality and health services: a review of aggregate data studies. J Epidemiol Community Health [Internet]. 1990 Jun [cited 2012 Jun 27];44(2):106–1Available from: http://www.ncbi.nlm.nih.gov/pubmed/2196328
Balkau B, Jougla E, Papoz L. European study of the certification and coding of causes of death of six clinical case histories of diabetic patients. EURODIAB Subarea C Study Group. Int J Epidemiol [Internet]. 1993 Feb [cited 2012 Jun 27];22(1):116–26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8449631
Hatton F, Facy F, Jougla E. [Mortality and morbidity of drug addiction increases in France]. Rev Epidemiol Sante Publique [Internet]. 1993 [cited 2012 Jun 27];41(5):422–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8284483
Jougla E, Goldberg M, Hatton F, Klein N, Letoullec A. [Relationship between the development of the health status and the activity of the health care system in developed countries]. Rev Epidemiol Sante Publique [Internet]. 1988 [cited 2012 Jun 27];36(6):464–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3068725
Bouvier-Colle MH, Inizan J, Hugny B, Michel E, Hatton F. [Sudden infant death in France during the winter of 1986]. Arch Fr Pediatr [Internet]. 1988 Jan [cited 2012 Jun 27];45(1):21–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3365100
Flahault A, Messiah A, Jougla E, Bouvet E, Perin J, Hatton F. Sudden infant death syndrome and diphtheria/tetanus toxoid/pertussis/poliomyelitis immunisation. Lancet [Internet]. 1988 Mar 12 [cited 2012 Jun 27];1(8585):582–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2894508
Benhamou D, Lienhart A, Auroy Y, Péquignot F, Jougla E. Accidents by ABO incompatibility and other main complications related to blood transfusion in surgical patients: data from the French national survey on anaesthesia-related deaths. Transfus Clin Biol. 2005 Nov;12(5):389–90.
Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005 Feb;34(1):121–30.
Salmon-Ceron D, Lewden C, Morlat P, Bévilacqua S, Jougla E, Bonnet F, et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005 Jun;42(6):799–805.
Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, et al. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. Scand J Infect Dis. 2005;37(6–7):482–7.
Carbonneil C, Donkova-Petrini V, Aouba A, Weiss L. Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses induced by dendritic cells generated in the presence of IFN-alpha. J Immunol. 2004 Jun 15;172(12):7832–40.
Bouvier AM, Remontet L, Jougla E, Launoy G, Grosclaude P, Buémi A, et al. Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):877–81.
Peng J, Ménégoz F, Lesec’h JM, Remontet L, Grosclaude P, Buémi A, et al. [Larynx cancer in France: descriptive epidemiology and incidence estimation]. Bull Cancer. 2004 Apr;91(4):363–8.
Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer. 2004 Jul 15;101(2):317–24.
Lienhart A, Auroy Y, Péquignot F, Benhamou D, Warszawski J, Bovet M, et al. [Preliminary results from the SFAR-iNSERM inquiry on anaesthesia-related deaths in France: mortality rates have fallen ten-fold over the past two decades]. Bull Acad Natl Med. 2004;188(8):1429–37; discussion 1437-1441.
Jougla E, Rican S, Péquignot F, Le Toullec A. [Socio-economic differences in mortality]. Rev Prat. 2004 Dec 31;54(20):2228–32.